Research Topics
| Rebecca BahnSummaryAffiliation: Mayo Clinic Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of graves ophthalmopathyAdina F Turcu
MD, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, 200 First Street Southwest, Rochester, Minnesota 55902
J Clin Endocrinol Metab 98:2153-9. 2013....
A stimulatory thyrotropin receptor antibody enhances hyaluronic acid synthesis in graves' orbital fibroblasts: inhibition by an IGF-I receptor blocking antibodySeema Kumar
Division of Pediatric Endocrinology and Metabolism, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55902, USA
J Clin Endocrinol Metab 97:1681-7. 2012..The expansion of orbital tissues involves accumulation of hyaluronic acid (HA) within the orbit...
Autoimmunity and Graves' diseaseR S Bahn
Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic School of Medicine, Mayo Clinic, Rochester, Minnesota, USA
Clin Pharmacol Ther 91:577-9. 2012..In addition, rituximab (RTX) is the first targeted biological therapy to be studied as treatment for these conditions...
Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical EndocrinologistsRebecca S Bahn Chair
Division of Endocrinology, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota 55905, USA
Thyroid 21:593-646. 2011..This article describes evidence-based clinical guidelines for the management of thyrotoxicosis that would be useful to generalist and subspeciality physicians and others providing care for patients with this condition...
Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of diseaseRebecca S Bahn
Division of Endocrinology, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota 55905, USA
J Clin Endocrinol Metab 88:1939-46. 2003
Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathyRebecca S Bahn
Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic Foundation, Rochester, Minnesota 55905, USA
Thyroid 12:193-5. 2002..Some of these may impact the expression of TSHr, the putative orbital autoantigen in this condition...
TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathyR S Bahn
Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic, Rochester, MN 55905, USA
J Endocrinol Invest 27:216-20. 2004..Alternately, locally enhanced expression of this protein at the sites of clinical disease may not be directly involved in pathogenesis, but could be secondary to the ongoing process, and nonetheless important in disease progression...
Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathyR S Bahn
Division of Endocrinology, Mayo Clinic Foundation, Rochester, Minnesota 55905, USA
J Clin Endocrinol Metab 83:998-1002. 1998..These results suggest that both the expression of this receptor and the accumulation of adipose tissue in the orbit in GO may be induced in vivo by a humoral factor(s) not present in the cell culture environment...
Thyrotropin receptor expression in cultured Graves' orbital preadipocyte fibroblasts is stimulated by thyrotropinR S Bahn
Division of Endocrinology, Mayo Clinic Foundation, Rochester, Minnesota 55905, USA
Thyroid 8:193-6. 1998..These studies suggest that the expression of this receptor in the orbit in vivo may be stimulated by TSH or other TSHr ligands, and that this stimulation may be important in the development of GO...
Understanding the immunology of Graves' ophthalmopathy. Is it an autoimmune disease?R S Bahn
Mayo Medical School, Rochester, Minnesota, USA
Endocrinol Metab Clin North Am 29:287-96, vi. 2000..Future studies using animal models and in vitro systems will allow definitive identification of the immune cell types, autoantigens, and autoantibodies involved in the pathogenesis of Graves' ophthalmopathy...
Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptorR W Valyasevi
Division of Endocrinology, Mayo Clinic Foundation, Rochester, Minnesota 55905, USA
J Clin Endocrinol Metab 84:2557-62. 1999..Furthermore, our studies support the concept that TSHr may be an important target antigen in this condition. Factors that stimulate adipocyte differentiation and TSHr expression in the orbit in GO have yet to be defined...
Induction of leptin expression in orbital preadipocyte fibroblastsD Z Erickson
Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic/Foundation, Rochester, Minnesota 55905, USA
Thyroid 11:221-6. 2001..This process would be expected to result in expansion of the orbital adipose tissues and increased TSHR expression within the orbit...
Effect of tumor necrosis factor-alpha, interferon-gamma, and transforming growth factor-beta on adipogenesis and expression of thyrotropin receptor in human orbital preadipocyte fibroblastsR W Valyasevi
Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic/Foundation, Rochester, Minnesota 55905, USA
J Clin Endocrinol Metab 86:903-8. 2001..In addition, the former two cytokines may play a role in determining the extent to which the volume of the orbital adipose tissue increases in this condition...
Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathyS C Jyonouchi
Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic Foundation, Rochester, Minnesota 55905, USA
Thyroid 11:929-34. 2001..These findings suggest that IL-6 may play a role in the pathogenesis of GO by increasing expression of the putative autoantigen within the adipose/connective tissues of the orbit...
A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathyC A Gorman
Division of Endocrinology, Mayo Clinic, Rochester, Minnesota 55905, USA
Ophthalmology 108:1523-34. 2001..Although widely used for more than 85 years, the efficacy of radiotherapy for Graves' ophthalmopathy (GO) has not been established convincingly...
Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studiesM A Frye
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, USA
Acta Psychiatr Scand 120:10-3. 2009..To assess the relationship between depressive relapse and change in thyroid function in an exploratory post hoc analysis from a controlled maintenance evaluation of bipolar I disorder...
A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves' ophthalmopathyR S Bahn
Department of Internal Medicine, Mayo Clinic Foundation, Rochester, Minnesota 55905
J Clin Endocrinol Metab 78:256-60. 1994..We suggest that the TSH receptor may be an important fibroblast autoantigen in GO and PTD, and that this mutant form of the receptor may have unique immunogenic properties...
Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptorSeethalakshmi Iyer
Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Best Pract Res Clin Endocrinol Metab 26:281-9. 2012..Future therapies for this condition may involve inhibition of thyrotropin receptor signaling in orbital fibroblasts...
Normal function in vivo of a homozygotic polymorphism in the human thyrotropin receptorR M Cuddihy
Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
Thyroid 5:255-7. 1995....
Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves' ophthalmopathySeema Kumar
Division of Pediatric Endocrinology, Clinic, Rochester, Minnesota 55905, USA
J Clin Endocrinol Metab 88:4246-50. 2003..In addition, the overexpression of IFN-gamma, without evidence of IL-4 or IL-5 expression, supports the concept that cell-mediated, rather than humoral, immunity plays the predominant role in pathogenesis of this disorder...
Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblastsRosanee W Valyasevi
Division of Endocrinology, Metabolism, and Nutrition, Mayo Clinic/Foundation, Rochester, Minnesota 55905, USA
J Clin Endocrinol Metab 87:2352-8. 2002..It is possible that endogenous PPARgamma ligands play a role in stimulating orbital adipogenesis in GO, and that future treatments may be aimed at antagonism of various components of the PPARgamma signaling system...
Retinal microvascular abnormalities in patients treated with external radiation for graves ophthalmopathyDennis M Robertson
Department of Ophthalmology, Division of Endocrinology, Mayo Clinic, Rochester, MN 55905, USA
Arch Ophthalmol 121:652-7. 2003..Radiation was directed to the orbits of 42 affected patients using 0.2 rad (20 Gy) delivered in 10 doses of 0.02 rad (2 Gy). Patients were periodically examined during a 3-year interval...
How perceived physician leadership behavior affects physician satisfactionRonald Menaker
Administrative Services, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Mayo Clin Proc 83:983-8. 2008....
Pathogenesis of Graves' ophthalmopathy: the role of autoantibodiesTeck Kim Khoo
Division of Endocrinology and Metabolism, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
Thyroid 17:1013-8. 2007..Although originally thought to represent another causative agent, antibodies to extraocular muscles are now generally thought to be secondary to extraocular muscle inflammation and damage...
The impact of overt and subclinical hyperthyroidism on skeletal muscleMichael D Brennan
Division of Endocrinology, Diabetes, Nutrition and Metabolism, Mayo Clinic, Rochester, Minnesota 55905, USA
Thyroid 16:375-80. 2006..This may have clinical relevance as SCH patients are often elderly and may therefore have concurrent sarcopenia of aging and would represent a previously unrecognized complication of SCH...
Thyroid transcription factor-1 in orbital adipose tissues: potential role in orbital thyrotropin receptor expressionKalyan K Bhattacharyya
Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota 55905, USA
Thyroid 15:422-6. 2005..The presence of mRNA encoding TTF-1 in orbital tissues and cultures suggest that this transcription factor may play an important role in extrathyroidal, as it does in thyroidal, TSHR expression...
Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesisSeema Kumar
Division of Pediatric Endocrinology, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA
J Clin Endocrinol Metab 90:4730-5. 2005..The signs and symptoms of Graves' ophthalmopathy (GO) result from inflammation and increased volume of the orbital adipose tissues and extraocular muscles...
Current perspective on the pathogenesis of Graves' disease and ophthalmopathyBellur S Prabhakar
Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612 7344, USA
Endocr Rev 24:802-35. 2003..Collectively, recent studies have led to a better understanding of the pathogenesis of GD and GO and have opened up potential new avenues for developing novel treatments for GD and GO...
Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathySeema Kumar
Division of Pediatric Endocrinology, Mayo Clinic, Rochester, Minnesota 55905, USA
J Clin Endocrinol Metab 89:930-5. 2004....
Clinical significance of diffusely increased 18F-FDG uptake in the thyroid glandDimitrios Karantanis
Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, Minnesota 55905, USA
J Nucl Med 48:896-901. 2007..Our purpose was to determine the clinical significance of diffusely increased (18)F-FDG uptake in the thyroid gland as an incidental finding on PET/CT...
Optic neuropathy of Graves disease: results of transantral orbital decompression and long-term follow-up in 215 patientsCacia V Soares-Welch
Division of Endocrinology, Diabetes, Metabolism, Nutrition and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Ophthalmol 136:433-41. 2003..CONCLUSIONS: Transantral orbital decompression appeared to be effective in treating optic neuropathy of Graves disease. Patient satisfaction was high at 10-year and 20-year follow-up...
The aftermath of orbital radiotherapy for graves' ophthalmopathyColum A Gorman
Department of Medicine, Mayo Clinic, Rochester, Minnesota. Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota 55905, USA
Ophthalmology 109:2100-7. 2002..In either case, the changes are of little clinical significance. Because it is neither effective nor innocuous, radiotherapy does not seem to be indicated for treatment of mild to moderate ophthalmopathy...
Effects of reducing the upper limit of normal TSH valuesVahab Fatourechi
JAMA 290:3195-6. 2003
Research Grants
- Thyrotropin Receptor Auto Antibodies in Graves' OphthalmopathyRebecca S Bahn; Fiscal Year: 2010..Our studies will yield information concerning mechanisms involved in disease development, and will determine the effectiveness of a novel approach to therapy. ..
- Thyrotropin Receptor Auto Antibodies in Graves' OphthalmopathyRebecca Bahn; Fiscal Year: 2009..Our studies will yield information concerning mechanisms involved in disease development, and will determine the effectiveness of a novel approach to therapy. ..
- Thyrotropin Receptor Auto Antibodies in Graves' OphthalmopathyRebecca Bahn; Fiscal Year: 2007..Our studies will yield information concerning mechanisms involved in disease development, and will determine the effectiveness of a novel approach to therapy. ..
- EYE IN GRAVES DISEASE--ROLE OF ORBITAL FIBROBLASTSRebecca Bahn; Fiscal Year: 2004..The main goal of the research program is to increase understanding of the orbital immune response in GO in order that novel and more specific therapeutic and preventive strategies for this condition might be developed. ..
- EYE IN GRAVES' DISEASE--ROLE OF ORBITAL FIBROBLASTSRebecca Bahn; Fiscal Year: 1993..The investigators believe these studies will enhance their understanding of disease pathogenesis which will translate into improve management strategies and eventually better clinical outcomes...
- Thyrotropin Receptor Auto Antibodies in Graves' OphthalmopathyRebecca S Bahn; Fiscal Year: 2010..Our studies will yield information concerning mechanisms involved in disease development, and will determine the effectiveness of a novel approach to therapy. ..
